San Diego, CA: Swastham has appointed Dr Sunil Deshmukh to the Board of Directors of its Indian entity, Sucheta Swastham Private Limited, while Rich Brady joins as Strategic Board Advisor to its US entity, Swastham, Inc.
The appointments will support the company’s efforts to scale its AI-powered lifestyle medicine platform globally.
Swastham has strengthened its global leadership with the appointment of Dr Sunil Deshmukh to the Board of Directors of Sucheta Swastham Private Limited, India, and Rich Brady as Strategic Board Advisor to Swastham, Inc., USA.
The appointments bring decades of international experience in business leadership, corporate governance, financial management, and organizational strategy to the company as it develops and scales its AI-powered platform to make expert-led lifestyle medicine accessible to millions of people worldwide.
Both leaders will contribute to Swastham’s long-term growth strategy as the company advances a technology platform designed to help healthcare experts scale their established lifestyle medicine protocols through governed AI, personalized digital engagement, and human expert oversight.
Dr Sunil Deshmukh Joins Swastham Board of Directors
Dr Sunil Deshmukh brings more than 30 years of international leadership experience across business management, corporate strategy, governance, and executive development.
He currently serves as Co-President of EMCC Asia Pacific, Global Board Director of the Institute of Management Accountants (IMA), and Managing Partner of Sunil Deshmukh C-Suite Lab.
Dr Sunil Deshmukh previously served as IMA Global Chair for 2024–25 and has held senior leadership positions at several organizations, including AM International Holdings – Singapore, Indo-Jordan Chemicals, McDonald’s India, and Foster’s India.
His experience in global business operations, board governance, and strategic leadership is expected to support Swastham as it strengthens its organizational foundations, expands partnerships, and pursues sustainable international growth.
Rich Brady Appointed Strategic Board Advisor
Alongside Dr Sunil Deshmukh’s appointment, Swastham has named Rich Brady as Strategic Board Advisor to its US entity.
Rich Brady is a retired US Marine Corps Colonel, business executive, and governance leader with extensive experience in financial management, strategy, and organizational leadership.
He currently serves as CEO of the Society of Defense Financial Management, a global professional association focused on advancing financial excellence across the defense sector.
Brady’s career spans military command, international affairs, corporate governance, and financial leadership.
In his advisory role, he will contribute perspectives on organizational strategy, financial stewardship, leadership development, and building scalable and resilient organizations.
His experience in leading complex organizations and navigating strategic challenges is expected to help Swastham establish a strong foundation for long-term growth.
Swastham Expands AI-Powered Lifestyle Medicine Platform
The leadership appointments come as Swastham works to develop an AI-powered platform that enables healthcare experts to transform their established lifestyle medicine protocols into scalable, personalized digital programs.
The platform combines expert-developed knowledge, governed AI, human oversight, and continuous engagement to expand access to lifestyle-based care for chronic conditions and other health challenges.
Swastham is initially focusing on metabolic and musculoskeletal health, including diabetes, obesity, and joint and muscle health. The company has a broader vision of expanding access to evidence-based lifestyle medicine across global markets.
Commenting on the appointments, Sucheta Godbole Deshpande, Co-founder and CEO of Swastham, said, “We are delighted to welcome Dr. Sunil Deshmukh and Rich Brady to Swastham at this important stage of our journey.
Dr. Sunil’s extensive experience in global business leadership, governance, and strategy, combined with Rich’s distinguished background in financial management and organizational leadership, will be invaluable as we build a responsible, scalable AI-driven health platform.
Their guidance will help us accelerate our mission while maintaining strong governance, operational discipline, and a long-term commitment to meaningful health impact.”
Dr Sunil Deshmukh also shared his views on joining the company’s Board of Directors.
“I am delighted to join the Board of Directors of Sucheta Swastham Private Limited at an exciting stage in the company’s journey,” said Dr. Sunil Deshmukh.
“Swastham has a compelling vision of combining the knowledge and experience of health experts with the power of AI to make lifestyle medicine accessible to millions of people. I look forward to working with Sucheta and the leadership team to help translate this vision into a scalable, sustainable business with meaningful impact on people’s lives.”
Rich Brady said he was honoured to support the company in his new advisory role.
“I am honored to support Swastham as a Strategic Board Advisor,” said Rich Brady. “The company is addressing an important challenge in healthcare by using technology to extend the reach of trusted health experts.
Building a successful organization around this vision requires strong leadership, sound governance, and disciplined execution. I look forward to contributing my experience and working with the team as Swastham grows and expands its impact.”
With the appointments of Dr Sunil Deshmukh and Rich Brady, Swastham is strengthening its leadership and governance as it prepares for the next phase of platform development, strategic partnerships, and market expansion.
About Swastham
Swastham, Inc., USA, and Sucheta Swastham Private Limited, India, are building an AI-driven health technology platform to make lifestyle medicine accessible at scale.
The platform enables healthcare experts to transform proven lifestyle protocols into personalized digital care programs using governed AI, human expert oversight, and continuous user engagement.
Initially focused on metabolic health and musculoskeletal conditions, Swastham aims to make expert-led lifestyle care more accessible, affordable, and scalable across geographies and languages.
